611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Health Sciences
Resources
Basic InformationLatest News
Blood Test Might Predict Worsening MSKeto Diet Might Change Your Gut in More Ways Than OneParkinson's Patient Improving After First-Ever Stem Cell TherapyKey Areas of the Brain Triggered in Recent Heart Attack SurvivorsFirst Good Evidence That Brain Hits 'Replay' While You SleepSome NFL Players May Be Misdiagnosed With Brain Disease: StudyGreenhouse Gases Bad for Your BrainTransplanted Skin Stem Cells Help Blind Mice See LightBrain Plaques Signal Alzheimer's Even Before Other Symptoms Emerge: Study'It's Like You Have a Hand Again': New Prosthetic Gets Closer to the Real ThingLosing a Spouse Could Speed Brain's DeclinePaddles Against Parkinson's: Ping Pong Might Ease SymptomsIn a First, Doctors Use Robotics to Treat Brain AneurysmSkiers Study Suggests Fitness May Stave Off Parkinson'sCRISPR Gene Editing Creates 'Designer' Immune Cells That Fight CancerGene Variant Ups Dementia Risk in Parkinson's Patients: StudyGene Variation May Protect Against Alzheimer's: StudyYoung-Onset Parkinson's May Start in the Womb, New Research SuggestsNew Gene Study Unravels Cancer's SecretsDoes Size Matter? Volume of Brain Area Not Always Tied to Memory, ThinkingGene Test Might Spot Soccer Players at High Risk for Brain TroubleSevere Deprivation in Childhood Has Lasting Impact on Brain SizeIn the Future, Could Exercise's Benefits Come in a Pill?Could Brain Scans Spot Children's Mood, Attention Problems Early?Brain Damage Changes Over Time in Boxers, MMA FightersSpecial 'Invisible' Dye Could Serve as Skin's Vaccination RecordCancer Drug Shows Promise for Parkinson's Patients'Smart' Contact Lenses Might Also Monitor Eye HealthCould Obesity Alter a Child's Brain Structure?Playing Sports Might Sharpen Your HearingAntarctic Study Shows Isolation, Monotony May Change the Human BrainCould MS Have Links to the Herpes Virus?Ultrasound Treatment Might Ease Parkinson's TremorsAnimal Study Offers Hope for Treating Traumatic Brain InjuriesA Gene Kept One Woman From Developing Alzheimer's -- Could It Help Others?Could AI Beat Radiologists at Spotting Bleeds in the Brain?Pro Soccer Players More Likely to Develop Dementia: StudyExtinct Human Species Passed on Powerful Immune System GeneScientists ID Genes Tied to Left-HandednessScientists Creating Gene Map of Human 'Microbiome'New DNA Blood Test May Help Guide Breast Cancer TreatmentFootball Head Trauma Linked Again to Long-Term Brain DamageMore 'Buyer Beware' Warnings for Unregulated Stem Cell Clinics3-D Printers Might Someday Make Replacement HeartsOne Gene Change 2 Million Years Ago Left Humans Vulnerable to Heart AttackHow to Protect Your DNA for Big Health BenefitsBones Help Black People Keep Facial Aging at BayGene Test Might Someday Gauge Your Heart Attack RiskDeep Brain Stimulation May Hold Promise in Alzheimer'sNeurology News Feed
Questions and AnswersLinksBook Reviews
Related Topics

Medical Disorders
Mental Disorders
Mental Health Professions

Blood Test Might Predict Worsening MS

HealthDay News
by By Serena Gordon
HealthDay Reporter
Updated: May 21st 2020

new article illustration

THURSDAY, May 21, 2020 (HealthDay News) -- A new blood test might help doctors predict whether someone's multiple sclerosis may soon get worse.

The test looks for a substance called neurofilament light chain. It's a nerve protein that can be detected when nerve cells die. People with higher levels of it were more likely to have worsening MS effects within the next year.

"In a disease like MS that is so unpredictable and varies so much from one person to the next, having a noninvasive blood test like this could be very valuable, especially since treatments are most effective in the earliest stages of the disease," lead investigator Ali Manouchehrinia said in a news release from the journal Neurology, where the study was published online May 20.

Manouchehrinia is an assistant professor of clinical neuroscience at the Karolinska Institute in Stockholm, Sweden.

His study of the neurofilament light chain blood test included almost 4,400 people with multiple sclerosis and a control group of more than 1,000 people without it.

In MS, the body's immune system attacks the central nervous system, commonly leading to problems with balance and walking that come and go.

Over five years, volunteers provided blood samples and their health was followed to see whose disability worsened. Researchers also checked for signs of a more serious form of MS called secondary progressive MS, in which disability gets worse little by little and then becomes more constant.

The study controlled the data to account for factors that might lead to worsening disability, such as length of time with MS.

People with MS had far more neurofilament light chain in their blood than did people without the disease, the study found.

And those with high levels of the nerve protein were 40% to 70% more likely to see their disability get worse within the next year compared to those with low levels.

Higher protein levels also translated to a 50% greater chance for a moderate disability that affected everyday life, but not people's ability to walk.

People with higher protein levels were also 50% more likely to develop a disability that impaired walking, but could still walk about one-third of a mile without help or taking a break.

Overall, 16% (525 people) had a moderate level of disability during the five-year study. Nine percent (352 people) developed significant disability.

While the test could predict a much higher risk of disability, it couldn't definitively show whether or not someone would have a disability.

Manouchehrinia said that it's possible that other medical conditions not studied may affect neurofilament light chain levels. More study is needed.

Dr. Asaff Harel, a neurologist at Lenox Hill Hospital in New York City, said the blood test may have a place with current MS monitoring such as MRI and physical exams.

"These results add to the growing body of literature looking at blood neurofilament light chain levels as a tool to predict long-term prognosis in MS," Harel said.

Mark Allegretta, vice president of research for the National Multiple Sclerosis Society, noted that the study was a large one, with more than 1,000 controls.

"This study adds a lot of confidence that neurofilament light chain levels will be useful in MS," he said.

Like Harel, Allegretta also predicted that the blood screening would one day be used in combination with other tests.

"With many of these tools, the information is additive. We're not looking to rely on any single test," he said.

Right now, MRI is used to track the course of the disease. But Allegretta said a blood test has advantages: It's more standardized than an imaging test and could be done more often and for a lower cost.

Allegretta said the test could be useful in clinical studies to see whether someone is responding to a treatment. It is at least a few years away, he added.

More information

Learn more about MS from the National Multiple Sclerosis Society.